Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
control group:western medicine symptomatic treatment
Sponsors
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for suspected and confirmed cases (including mild, general, and severe) in the Diagnosis and Treatment of Pneumonia of New Coronavirus Pneumonia (Trial Version 5); 2. Meet the TCM diagnostic criteria for each stage of the novel coronavirus pneumonia; 3. Aged 18-75 years-old men or women; 4. Patients who volunteer to participate in this study and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with respiratory failure, acute necrotizing encephalopathy, septic shock, multiple organ dysfunction, and other serious clinical conditions requiring monitoring and treatment when enrolled; 2. Pregnant, preparing or lactating women; 4. Patients with severe heart, cerebrovascular and liver, kidney, hematopoietic system diseases and mental illness; 3. Patients with tuberculosis, measles, AIDS and other infectious diseases; 5. Patients with known allergies to western medicine or traditional Chinese medicine ingredients used in this research; 6. Patients with gastrointestinal bleeding who cannot take Chinese medicine; 7. Patients who use oral Chinese medicine within 4 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of worsening events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total duration of disease;Average length of hospital stay;Time needed for healing;Negative rate of respiratory virus nucleic acid;Time from treatment to the beginning of antipyretic;Time from treatment to complete antipyretic;Chest imaging;Incidence of adverse events; | — |
Countries
China
Contacts
Public ContactLU Zhenhui
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed